EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx only, Manufactured by: Pacira Pharmaceuticals, Inc. San Diego, CA 92121. NDC: 65250-266-20,

Recall Number: D-0621-2020

Firm: Pacira Pharmaceuticals, Inc.

Classification: Class II

Status: Terminated

Report Date: 20191211

Initiation Date: 20191121

Termination Date: 20200603

Sub Potent Drug: Out of Specification (OOS)

EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx only, Manufactured by: Pacira Pharmaceuticals, Inc. San Diego, CA 92121. NDC: 65250-266-20,